GenoCure.AI · raw details

AI Driven Personalized Cancer Therapy · Jerusalem · Founded 2024

active Pre-Seed ← back to profile

Highlights

1 patentProfile claimed by owner

About

AI Driven Personalized Cancer Therapy

GenoCure.AI is transforming oncology by integrating advanced AI with deep genomic analysis to personalize cancer treatment strategies. The company provides physicians, healthcare providers, and pharmaceutical companies with actionable insights to enhance therapeutic efficacy and improve patient outcomes. The company developed the Supreme™ Platform - a proprietary system that combines multi-omic data with AI-driven algorithms to identify effective therapeutic combinations tailored to each patient's unique tumor profile.

GenoCure.AI aims to bridge the gap between scientific discoveries and clinical applications in oncology.

Identity

NameGenoCure.AI
Sluggenocure-ai
Type / kindstartup
Source _idGcf60T311Mgke7B3GUS7g4icDiCqifzN07aESMFkeTcSlZKRV9LgHK

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityJerusalem
HQ addressHadassah Ein Kerem Campus (Ishpro, Jerusalem, Israel

Web & social

Websitehttps://www.genocure.ai/
LinkedInhttps://www.linkedin.com/company/genocure-ai/?viewAsMember=true

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life Sciences
Business models
B2B2CB2B
Tags
digital-healthcarehealthcareartificial-intelligencemachine-learningsaasalgorithmsprecision-medicinecancercloud-platformmolecular-biology

Funding

Total raised$520K
Current stagePre-Seed

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}